CD4 and cancer: Cells with antitumor effects, such as CD8+ T cells, CD4+ T cells, B cells and plasma cells, presented negative correlations with the Riskscore, while cells with pro-cancer functions, such as M2 macrophages and cancer-associated fibroblasts, presented positive correlations (Fig. 5C).